BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 15163328)

  • 1. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
    Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
    Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbimazole induced ANCA positive vasculitis.
    Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
    J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
    Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
    Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
    Miller RM; Savige J; Nassis L; Cominos BI
    Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
    Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
    J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
    Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
    Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
    Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease].
    Fujii T; Kawamata T; Ueda S; Akikusa B; Hasegawa S; Tsukahara T; Iesato K; Ogawa M; Saisho H
    Nihon Jinzo Gakkai Shi; 2003; 45(8):771-7. PubMed ID: 14737995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.